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ABSTRACT 
BACKGROUND AND OBJECTIVES 
Perinatal asphyxia is a common neonatal problem at times devastating 
because of its potential for causing permanent damage and even death of 
the fetus or newborn infant. Only a third of deliveries in India are 
institutional and many asphyxiated babies are brought late to hospitals. In 
the absence of perinatal records, it is difficult to retrospectively diagnose 
perinatal asphyxia. There is a need to identify neonates with asphyxia who 
will be at high risk for hypoxic ischemic encephalopathy and multi-organ 
dysfunction.  
The value of the present biochemical parameters used for diagnosing 
asphyxia is inadequate and controversial. The main objective of this study 
was to evaluate  prospectively the value of measuring uric acid to creatinine 
(UA/Cr) ratio in early spot  urine  samples  in  diagnosing  perinatal  
asphyxia,  and  to   assess  the relationship between the urinary uric acid 
to creatinine ratio and the severity of HIE. 
METHODS 
The study was performed from January 2016 to July 2016 in the 
Neonatal Intensive Care Unit of Rajah Mirasdar Hospital, Thanjavur. The 
  
case group consisted of 50 asphyxiated full term neonates who fulfilled the 
inclusion and exclusion criteria. The control group consisted of 50 full term 
neonates with no signs of asphyxia after an uncomplicated pregnancy. The 
spot urine samples were collected within 6-24 hours of birth and sent for  
uric acid and creatinine analysis.  Urinary uric acid to creatinine (UA/Cr) 
ratio value of >1.22 was taken as the cut-off level. Sensitivity, specificity, 
Positive predictive value (PPV), Negative predictive value (NPV) were 
calculated. 
RESULTS 
The Urinary UA/Cr ratios were found to be higher in asphyxiated 
infants (2.59±1.04) when compared with those in the controls (0.72±0.16, 
P<0.001). UA/Cr ratios were significantly higher in infants with severe HIE 
(Stage 3) (4.29±0.46) when compared with infants with moderate HIE 
(Stage 2) (2.79±0.74) and those with mild HIE (Stage 1) (2.66±0.70). A 
significant correlation was also detected between the UA/Cr ratio and the 
severity of HIE in the asphyxiated group. The cut-off value of UUA/Cr of 
>1.22 has a sensitivity of 86%,  specificity of 92%, positive predictive 
value of 91.49%,  negative predictive value of 86.49% and an accuracy of 
89% in diagnosing asphyxia among term neonates. 
 
 
  
 
INTERPRETATION AND CONCLUSION 
The urinary uric acid/creatinine ratio was found to be a quick, 
inexpensive, non invasive, reliable, early biochemical marker of perinatal 
asphyxia. 
KEY WORDS 
Perinatal asphyxia, urinary uric acid/creatinine ratio, hypoxic ischemic 
encephalopathy (HIE). 
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INTRODUCTION 
Perinatal asphyxia is a common neonatal problem which significantly 
contributes to neonatal morbidity and mortality. Birth asphyxia is estimated 
to account for 23% of the 4 million neonatal deaths globally1. An estimated 
1 million children who had neonatal asphyxia live with chronic 
neurodevelopmental morbidities including mental retardation, learning 
disabilities and cerebral palsy. 
 In India, 2.5 - 3.5 lakhs  neonates  die each year in the first three days 
of life because of birth asphyxia 2. In India according to national neonatal 
perinatal database (NNPD), asphyxia contributes to 20% of death in 
neonates. In India, 8.4% of inborn babies have one minute Apgar score less 
than 7 and among these babies 1.4% suffer from hypoxic ischemic 
encephalopathy (HIE) 2.  
 The signs of perinatal asphyxial  injury are non specific and overlap 
with other illness. It is difficult to diagnose perinatal asphyxia 
retrospectively without perinatal records. Although asphyxia is associated 
with multi organ dysfunction, management is basically supportive. So there 
is a need to identify infants who are at high risk for HIE and early neonatal 
mortality as a result of neonatal hypoxia. A variety of markers have been 
examined to identify perinatal hypoxia including cord pH, fetal heart rate 
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monitoring, EEG, neuroimaging like CT and magnetic resonance image 
scans and Doppler studies. 
  In a term neonate, perinatal asphyxia affects major systems resulting 
in renal, neurologic, cardiac and lung dysfunction in 50%, 28%, 25% and 
23% cases respectively. The extent of multi organ dysfunction determines 
the outcome, either the neonate succumbing as a consequence of organ 
damage or recovering. 
 HIE is the foremost concern in asphyxiated neonates because it has 
the potential to produce serious long term neuromotor sequelae among 
survivors. Neonatal asphyxia is one of the leading causes of neonatal 
mortality in developing countries. 3% to 13% of infants with cerebral palsy 
show evidence of intrapartum asphyxia3. Cellular metabolism needs 
adequate oxygen supply. Brief hypoxia affects cerebral oxidative 
metabolism leading to an anaerobic glycolysis to generate ATP. In 
anaerobic conditions one molecule of glucose produces two molecules of 
ATP as opposed to 30 molecules of ATP produced in aerobic condition. 
Anaerobic metabolism results in production of large quantities of metabolic 
degradation products like lactic acid 4,5,6,7,8. If there is prolonged hypoxia, 
cardiac output will fall and cerebral blood flow is compromised. A 
combined hypoxia ischemic insult produces further failure in oxidative 
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phosphorylation and ATP production, sufficient enough to cause cellular 
damage. Lack of ATP and increase in excitotoxic cellular damage leads to 
accumulation of adenine diphosphate (ADP) and adenosine monophosphate 
(AMP), which is catabolised to adenosine, inosine and hypoxanthine 4,5,6,7,8. 
If continuous tissue hypoxia persists, increased hyoxanthine is oxidised to 
xanthine and uric acid in the presence of xanthine oxidase and the level of 
uric acid level is increased in blood and excreted in urine 4,5,6,7,8 . 
 This study is to evaluate the utility of urinary uric acid to creatinine 
ratio (UA/Cr ratio) as a cost effective, non invasive and at the same time 
early biochemical marker for predicting the severity of asphyxia.  
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AIMS AND OBJECTIVES OF THE STUDY 
 
1) To estimate the urinary uric acid and creatinine among the 
asphyxiated and non-asphyxiated term neonates. 
2) To validate the urinary uric acid to creatinine ratio (UA/Cr ratio) 
as non-invasive, easy, cheap method to diagnose asphyxia among 
neonates. 
3) To determine the relationship between the urinary UA/Cr ratio and 
the severity of HIE. 
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REVIEW OF LITERATURE 
Historical data 
The term birth asphyxia has several intriguing issues in historical 
perspective. First, there is no satisfactory definition. Clinicians, pathologists 
and biochemists are using the phrase, but there is no universal definition. 
Dr. Eastman of Hopkins termed asphyxia “an infelicity of etymology” since 
Greek derivation gives the definition “without pulse”. In pathology, 
asphyxial lesion is defined without any clinical or biochemical evidence of 
hypoxia whereas, in physiology asphyxia is defined as hypoxia plus 
hypercarbia. 
Dr. N. J. Eastman was the pioneer in the study of birth asphyxia. He 
defined birth asphyxia as “an inability of the child to breath and apnea 
associated with deficiency of oxygen during labour”. His initial work was 
related to the initiation of respiration after birth.9 
 Eastman first studied the concentration and delivery of oxygen in 
maternal and umbilical blood samples using 16 patients. He then used them 
as controls in his next study for identifying the deviations from normal. In 
his next study, he determined the lactate levels in cord blood in 24 neonates 
of which, 7 had birth asphyxia. Three of these neonates died. He explained 
the maternal-fetal lactate relationships and he correlated the relationship 
between the absence of hyperlactatemia and fetal oxygen adequacy10. Then 
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he measured the carbon dioxide and pH in normal and abnormal fetal and 
maternal blood. Lastly, he demonstrated that neonatal acidosis accompanies 
asphyxia 11. 
 There is no review of birth asphyxia without including the Apgar 
score. Dr. Apgar, in her research paper published in 1953, was obviously 
disturbed by the lack of specificity in resuscitation 12. She described the lack 
of proper systemic evaluation of newborns and further therapeutic 
intervention based on the initial evaluation. She chose her criteria in such a 
way that it could be delineated without interfering and compromising with 
the ongoing resuscitation efforts. She then correlated her score with other 
variables like perinatal mortality and type of anesthesia. She showed that 
there existed an inverse relationship between the score and the need for 
active resuscitation. She designed her scores in such a way that the focus of 
attention is on the baby and its immediate needs, as well as to objectify and 
systematize the process for observer communications. 
 Since the primary goal is prevention, a variety of markers are 
examined for identifying perinatal hypoxia. This includes electronic fetal 
heart monitoring, Apgar scores, intrapartum fetal scalp blood pH, cord pH, 
EEG, CT, MRI and Doppler studies. The current problem, from a historical 
perspective, is lack of ability to differentiate the false positively diagnosed 
neonates from the neonates who truly had asphyxia. 
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 Basu et al had done a study in which estimated urinary uric acid and 
creatinine ratio within 24 hours was higher in asphyxiated than the non 
asphyxiated neonates 13. 
 Ciler Erdag and Vitrinel showed that the mean uric acid and 
creatinine ratio in the first 24 hours of birth was more in asphyxiated 
neonates than non asphyxiated neonates 14. 
 Chen et al showed that urinary UA/Cr ratio may be used as an early 
marker of perinatal asphyxia. In both term and preterm infants, a higher 
urinary uric acid to creatinine ratio was found in asphyxiated neonates than 
in non asphyxiated neonates 15. 
 Akisu et al reported that urinary UA/Cr ratio was found to be higher 
in neonates with asphyxia than in neonates without asphyxia and it was 
effective in assessing severity of asphyxia 16. 
  Bader et al showed that urinary uric acid and creatinine ratio may be 
used as a marker of neonatal asphyxia in term and preterm neonates and it 
was significantly higher in asphyxiated group than in non asphyxiated 
group. They concluded that the ratio might be used as an indicator of 
severity of neonatal asphyxia 17. 
 Banupriya et al reported that urinary uric acid excretion rate is higher 
in asphyxiated neonates than non asphyxiated neonates and it may be used 
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as biochemical marker for severity, evaluation and death prediction in 
neonatal asphyxia 18. 
Dong Wen Bin and coworkers concluded that urinary uric acid to 
creatinine ratio is more in asphyxiated neonates than non asphyxiated 
neonates. It might be used as an indicator for early assessment for severity 
of asphyxia and post asphyxia renal injury in neonates 19. 
 Reem Mahmoud and Dina El Abd found significant correlation 
between the urinary uric acid to creatinine ratio and the severity of HIE in 
asphyxiated neonates (r= 0.94, p<0.001) and the ratio was found to be a 
good and simple screening test for the early assessment of perinatal 
asphyxia 20. 
 Tekgul et al 21 found the measurement of interleukin in CSF with a 
cut off value25.9 pg/ml had the highest predictive value among all other 
biochemical markers of perinatal asphyxia. He suggested that interleukin 6 
measurements in CSF is superior to urinary UA/Cr ratio as a tool to 
diagnose neonatal asphyxia, but the test is sophisticated, expensive and 
invasive compared to urinary UA/Cr ratio which is simple, cheap and safe 
and hence may be used as a screening test. 
 Jensen et al22 and Hasday and Grum23 found increased uric acid in 
urine of asphyxiated neonates. 
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Neonatal asphyxia (perinatal asphyxia) 
Birth asphyxia is the most important and common cause of cerebral 
injury occurring in neonates. The term is used to imply an abnormal process 
and if untreated may cause permanent injury. Hypoxia and hypo perfusion 
both contribute to asphyxia impairing tissue gas exchange resulting in tissue 
acidosis. Since there is simultaneous occurrence of hypoxia and ischemia, 
the term hypoxia ischemic insult is preferred now. Undoubtedly hypoxia-
ischemia leads to brain injury but the major concern in these neonates is the 
development of long term neurodisability such as cerebral palsy. In these 
children there is often a false assumption that they were injured during 
events of labour and delivery, with the result that obstetricians and 
midwives are targeted as the person responsible for those neurologic 
injuries24.  
 Birth asphyxia is defined as “the failure to initiate and sustain 
breathing at birth” by World Health Organization 25.   
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An Apgar score at 1 minute of 0-3 defines severe birth asphyxia and 
4-7 defines moderate asphyxia according to International classification of 
Disease (ICD 10) 26. 
 The following terms are used in evaluating a term infant at risk for 
brain injury in the perinatal period. 27   
A. Neonatal depression 
It is a clinical, descriptive term that relates to the condition of the 
neonate on physical examination in the immediate postnatal period (in the 
first hour of birth). In this condition infants have depressed mental state, 
hypotonia and possibly difficulties in spontaneous respiration and functions 
of cardiovascular system. 
B. Neonatal encephalopathy 
It is a clinical term used to describe an abnormal neuro behavioural 
state that includes decreased level of consciousness with abnormal neuro 
motor tone. It is associated with seizure-like activity, hypo ventilation or 
apnea, depressed primitive reflexes.  It does not signify a specific etiology, 
nor does it imply irreversible neurologic injury as it can be caused by 
reversible conditions like hypoglycemia or maternal medications. 
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C. Hypoxic-ischemic encephalopathy (HIE) 
It is an abnormal neurobehavioural state having impaired cerebral 
blood flow. 
D. Hypoxic-ischemic brain injury 
It is attributed to hypoxia and/or ischemia as evidenced by 
biochemical [such as serum creatine kinase brain bound (CK-BB)], 
Electrophysiological (EEG), neuroimaging (cranial ultrasonography, CT, 
MRI). 
Incidence 
      The frequency in developed countries with advanced neonatal/obstetric 
care is approximately 1 to 1.5% of live births and it is inversely related to 
birth weight and gestational age. It occurs in 0.5% of live born newborns   
>36 weeks of gestation and accounts for 20% of perinatal deaths. Infants of  
diabetic mothers, breech presentation, infants having  intrauterine growth 
retardation are in higher risk for perinatal asphyxia27. In India, 8.4% of 
inborn babies have a Apgar score of less than 7 at 1 minute, but only 1.4% 
suffer from HIE. 
Etiology 
In term infants, asphyxia events take place in the antepartum or 
intrapartum period due to impaired gas exchange across the placenta which 
cause insufficient oxygen supply and impaired removal of carbondioxide 
12 
 
(CO2) and hydrogen from the fetus. Asphyxia due to pulmonary, 
neurological or cardiovascular problems can occur in the post partum 
period 27. 
A. Factors which predispose to neonatal asphyxia include: 
Impairment of oxygenation in mother. 
Impaired blood flow from mother to placenta. 
Impaired blood flow from placenta to fetus. 
Decreased gas exchange across the placenta or at the fetal tissue level. 
Increased fetal O2 requirement. 
B. Etiology of neonatal hypoxia-ischemia include: 
• Maternal factors: hypertension (acute or chronic), infection, 
diabetes, hypotension, and hypoxia due to pulmonary, cardiac or 
neurologic disease, drug use and vascular disease. 
• Placental factors: infarction, hydrops, abruption 
• Uterine rupture. 
• Umbilical cord factors: prolapse, compression, entanglement of 
umbilical cord, vascular abnormalities 
• Fetal   factors:   anemia,   infection, hydrops, cardiomyopathy. 
• Neonatal factors: neonatal hypoxia occurs in cyanotic congenital 
heart disease, persistent pulmonary hypertension, cardio 
myopathy. 
13 
 
 
Assessment of fetal well being 
The well being of the fetus is predicted using many assessments 
during and after delivery such as elective fetal heart rate monitoring by 
cardiotocograph (CTG), Apgar scores, meconium staining of amniotic fluid 
and cord blood arterial pH. 
Meconium staining of amniotic fluid 
       Heavy or thick meconium staining is considered as a marker of severe 
asphyxia. The incidence of meconium stained amniotic fluid complicating 
deliveries is 8-25% of the live births. Meconium aspiration syndrome 
develop in 5% of these neonates who are born through meconium stained 
amniotic fluid and 0.4% of these neonates developed cerebral palsy 
subsequently.  Furthermore if we take cerebral palsy as an endpoint of 
severe asphyxial injury in perinatal period, then 99.6% of infants of normal 
birth weight with meconium staining had no evidence of this condition 28.  
Electronic fetal monitoring 
 Continuous use of electronic fetal monitoring has not shown to reduce 
perinatal mortality or asphyxia when compared with auscultation by trained 
personnel, but has increased the incidence of operative delivery 27. When 
used these monitors simultaneously record fetal heart rate and uterine 
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activity for ongoing evaluation. The following are the parameters of fetal 
monitoring 
1. Baseline heart rate is between 110 and 160 beats per minute normally. 
The baseline heart rate must be apparent for a minimum of 2 minutes in 
any 10 minutes segment and must not show episodic changes, periods 
of marked fetal heart rate variability or segments of baseline heart rate 
that differ by more than 25bpm. Basal fetal bradycardia is defined as 
FHR <110 bpm due to congenital heart block associated with 
congenital heart malformation or maternal systemic lupus 
erythematosus. Baseline tachycardia is defined as FHR>160 bpm, due 
to fetal dysrhythmia, hyperthyroidism, maternal fever or 
chorioamnionitis. 
2. Beat-to-beat variability is recorded with the help of RR interval. In   
awake term neonates beat to beat variability is 5 to 25 beats/minute. 
Fetal CNS depression due to fetal immaturity, sleep, maternal 
medications like sedatives, intravenous magnesium sulphate, 
narcotics cause reduced beat to beat variability. 
3. In Non stress test, FHR are reassuring, if there is accelerations present. 
4. Decelerations of the FHR are benign and indicates fetal compromise 
depending  on  their  characteristic,  shape  and  timing  in  relation  to  
uterine contractions. 
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a) Early decelerations are symmetric in shape. They are benign and 
have good beat-to-beat variability. These decelerations are 
commonly seen in active labour when the fetal head is 
compressed against the maternal pelvis, resulting in a 
parasympathetic effect. 
b) Late decelerations are apparent decrease in the FHR associated 
with uterine contractions. The onset, nadir and recovery of the 
deceleration occur after the beginning, peak and end of the 
contraction, respectively. It is significant when there is a fall in 
the heart rate of only 10 to 20 beats/minute below baseline (even 
if still within the range of 110-160). Late decelerations are 
because of uteroplacental insufficiency and possible fetal 
hypoxia. As the uteroplacental insufficiency worsens, (i) beat-to-
beat variability will be lost, (ii) decelerations will be lasting 
longer, (iii) they will begin sooner following the onset of a 
contraction, (iv)  they will take longer to return to baseline, and 
(v) the rate to which the fetal heart slows will be lower. 
Repetitive late decelerations need action. 
c) Variable decelerations vary in their shape and in their timing 
relative to contractions. They are due to fetal umbilical cord 
compression. Variable decelerations assume significance if they 
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are severe (down to a rate of 60 beats/minute or lasting for 60 
seconds or longer, or both), associated with poor beat-to-beat 
variability or mixed with late decelerations.   
Apgar score  
Apgar score is a method of describing the condition of an infant at 
birth described by Virginia Apgar 29. Using  heart rate, respiratory efforts, 
tone, reflex activity and colour, a score is determined at 1 minute then at 5 
minute intervals as necessary (maximum score 10) 30 (Table 1). The ICD-10 
definition for birth asphyxia is based on the 1 minute Apgar score. Asphyxia 
with Apgar score of 0-3 at 1 minute defines severe asphyxia according to 
ICD-10, 4-7 defines moderate asphyxia according to ICD-10 31. Regarding 
prognosis, Apgar scores in individual cases do not appear to correlate with 
outcome and hence are frequently interpreted incorrectly for long term 
prognostication32. Despite the controversy, this definition of severe birth 
asphyxia appears useful in identifying a high risk group which requires 
further follow up of their neurological status. 
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Table 1: Apgar Scoring system   
 
 
     The 1 minute Apgar score is an index of intrapartum depression this 
correlates with the umbilical cord blood pH measurements. 1 minute Apgar 
scores do not correlate with outcomes. Apgar scores beyond 1 minute reflect 
the changing condition of the infant. It also reflects the adequacy of the 
resuscitative measures undertaken. Persistent low Apgar scores correlates 
with the baby’s underlying condition. It also indicates the need for further 
therapeutic efforts (Table 1) 3. 
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Table 2: Clinical criteria necessary to establish that acute Neurological 
injury in the newborn was related to "Asphyxia" proximate to 
delivery34,35 
 
Profound metabolic or mixed academia (pH<7.0) determined by an 
umbilical cord arterial sample, if obtained 
Apgar score of 0–3 for longer than 5 min 
Neonatal neurological manifestations - e.g., seizures, coma, or hypotonia 
Multi system organ dysfunction - e.g., cardiovascular, gastrointestinal, 
hematological, pulmonary or renal system 
 
Acidosis 
 Acidosis is a marker of CO2 accumulation (respiratory acidosis) and/ 
or metabolic acidosis as the result of anaerobic metabolism. Severe fetal 
cord blood acidosis is a marker of impaired gas exchange. Metabolic 
acidosis is an index of anaerobic metabolism and used as retrospective 
evidence of tissue hypoxia and fetal distress. However, umbilical arterial 
acidemia at delivery, considered on its own, will not be associated with poor 
outcome 36. It has been associated with poor outcome in combination with 
abnormal fetal heart rate patterns, depressed Apgar score and significant 
HIE 37. 
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There is poor correlation between cord blood acidosis and depression 
of Apgar scores. Severe fetal acidosis (pH <7.00) occurs in 2.5per 1000 
term infants, representing intrapartum compromise possibly severe enough 
to be associated with organ dysfunction, but only a minority of infants had 
neurological complications 38 . So there is only a very loose association 
between fetal acidosis and severe fetal distress 39.  
 The umbilical cord blood arterial pH is more representative of the 
fetal metabolic status and arterial acidemia may occur with normal venous 
pH. Hence sampling of venous blood alone is not recommended.  Umbilical 
cord blood pH estimation excludes birth asphyxia as the diagnosis in 80% of 
neonates who are depressed at birth40.  
 The incidence of seizures and neonatal mortality is increased in 
infants with an umbilical artery pH <7.0 after birth. But even below this low 
level, the specificity is low with normal outcome reported in as many as 
80% of neonates with an umbilical artery pH <7.041. 
 Non reassuring fetal heart rate patterns, prolonged labour, meconium 
stained amniotic fluid, a low 1 min Apgar score and mild to moderate 
acidosis have no predictive value for long term neurological injury without 
signs of encephalopathy and seizures 42. So it is essential that entire 
pregnancy, labour, delivery and the period well beyond birth are examined 
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to understand fully the pathophysiological mechanisms that are responsible 
for any brain injury and its long term impact 24.  
Fetal response to hypoxia-ischemia: 
The healthy neonate has variety of adoptive responses in order to 
overcome the hypoxic insult. These includes 43 
• Reduction of body and breathing movements and rapid eye movement 
sleep which in turn reduces the energy consumption and demand of 
oxygen. 
• Increased oxygen extraction from blood ; The maternofetal 
circulation represents a high output oxygen supply in which almost 
twice the amount of oxygen can be extracted by fetal haemoglobin 
before cardiac output needs to be increased. Erythropoietin 
concentration is increased, which stimulates fetal erythrocyte 
production. 
• Redistribution of blood supply to central nervous system, 
myocardium and adrenals at the expense of kidneys, gastrointestinal 
tract, muscle and liver. 
• Within the brain, blood flow is diverted to brainstem, cerebellum and 
midbrain.  
• Sympathetic response: Hypoxia increases catecholamine levels  
which leads to increased peripheral vascular resistance and 
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myocardial contractility to maintain perfusion. It accelerates 
anaerobic glycolysis, which mobilizes glycogen stores from liver to 
maintain the CNS and myocardial energy substrate. 
• The immature CNS utilize the pyruvate, ketones and lactate produced 
by anaerobic glycolysis easily as an alternative to glucose. Babies 
with hyperinsulinemia (eg. those born to mothers with diabetes) are 
not able to generate these alternative sources effectively and therefore 
are at risk for hypoxic-ischaemic injury. 
Clinical features after birth: 
Hypoxic –ischaemic encephalopathy (HIE) 
Neonatal encephalopathy refers to abnormal neurological behaviour 
in the neonatal period and it is due to wide range of causes. If a neonate has 
been affected by hypoxic-ischemic event at delivery, the infant will have 
disturbance in neurological behaviour that is referred as HIE. Infants have 
sequence of altered behavioral changes lasting for days depending on the 
severity and duration of the asphyxia. Grading systems are used to define 
degree of encephalopathy. Sarnat and Sarnat 44 introduced grading system 
for HIE (Table 3) and it was modified later by Levene MI 45 (Table 4). 
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Table 3: Sarnat and Sarnat Stages of Hypoxic-Ischemic       
               Encephalopathy 
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Table 4: A clinical grading system for hypoxic-ischaemic 
encephalopathy by Levene MI. 45 
 
 
Mild (Grade-1) encephalopathy 
 This is characterized by hyper alertness, staring (decreased frequency 
of blinking), normal or decreased spontaneous motor activity and a lower 
threshold for all stimuli including the easily elicited Moro reflex. Seizures 
are not a feature of Grade I encephalopathy. 
Moderate (Grade II) encephalopathy 
 Seizures occur commonly. There is lethargy, hypotonia with reduced 
spontaneous movements, a higher threshold for primitive reflexes, and 
mainly parasympathetic responses. A consistent feature is differential tone 
between the upper and lower limbs, with the arms being relatively hypotonic 
compared to the legs. 
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Severe (Grade III) encephalopathy 
 These neonates are comatose, with hypotonia and no spontaneous 
movements. Primitive reflexes and the suck reflex are often absent. 
Seizures may be frequent and prolonged, although in the most severe cases 
there may be no seizure activity and an isoelectric EEG. 
 Asphyxia is not the only cause of neonatal encephalopathy and 
alternative causes such as hypoglycemia and meningitis must be considered 
and excluded before attributing asphyxial insult as the cause of HIE 46.                
In particular, neonatal convulsions alone with clinical inter seizure 
normality are not a feature of HIE, nor is the baby who shows an 
unchanging pattern of neurological abnormalities in the neonatal period. It 
has been suggested that in the majority of cases, ‘neonatal encephalopathy’ 
in full-term babies may not be due to intrapartum events, but may originate 
in the antepartum period47. The severity of HIE is the best clinical method 
currently available to predict subsequent outcome following asphyxia, but it 
has a number of disadvantages. Firstly, the severity of HIE can only be 
determined retrospectively, as the clinical neurological features of asphyxia 
take some time to evolve. Secondly, other organs such as the kidneys and 
heart may be compromised due to asphyxia but the fetus preserves blood 
flow to its brain  thereby sparing cerebral function. The lack of 
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encephalopathy does not necessarily indicate that the infant has not suffered 
from significant intrapartum asphyxia 48. 
Other neurologic considerations 49: 
 Increased intracranial pressure is due to cerebral edema in HIE. 
Cerebral edema peaks at 36 to 72 hr after insult. It often reflects extensive 
prior cerebral necrosis rather than swelling of intact cells, making this 
finding consistent with a uniformly poor prognosis. Effects to reduce ICP 
and cerebral edema do not affect outcome. 
 Seizures develop in 20% to 50% of infants with HIE and usually 
occur between 6 and 24 hours of hypoxic insult. They are mostly seen in 
Sarnat stage 2 HIE, rarely in Sarnat stage 3 and almost never seen in Sarnat 
stage 1 HIE. 
 Seizures in HIE are subtle, tonic or multifocal clonic in nature. 
Generalised seizures are uncommon due to comparatively immature 
myelination and synaptogenesis of the neonatal brain. 
 Seizures may be associated with increased cerebral metabolic rate, 
which further leads to cerebral injury. 
 Seizures compromise ventilation and oxygenation, especially in 
neonates who are not on mechanical ventilation. In neonates who are 
paralysed for mechanical ventilation, seizures may be manifested by abrupt 
changes in blood pressure, heart rate and oxygenation. 
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 Seizures associated with HIE may require more than one anti-
convulsant for control. 
Prognosis after HIE  
In meta-analysis studying neonatal outcome with HIE stages showed, 
Stage I (mild HIE) no increased risk of disability or death50. Significant 
reduction in intelligence quotient at 8 years has been reported in stage II 
(Moderate HIE), compared to neonates in grade I HIE 51. 
 Specific outcomes depend on the severity of encephalopathy, 
presence or absence of seizures, EEG results and neuroimaging findings 
1. Sarnat clinical stage I or mild HIE 
 98-100% will have normal neurologic outcome with less than 1% 
mortality 52. 
2. Sarnat clinical stage II or moderate HIE 
           20% - 37% have abnormal neurological outcome or die. Infants in 
stage 2 for >7 days have poorer outcomes. Prognosis can be predicted with 
the use of EEG to diagnose seizure activity and MRI to assess the severity 
of encephalopathy and the location of hypoxic ischemic brain injury. 
3. Sarnat clinical stage III or severe HIE 
50-89% die and all have major neuro developmental impairment. 
 Prognosis is considered to be good if neonates do not progress to 
stage 3 and remains in stage 2 for <5 days. 
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 The presence of seizures increases the risk of CP to 50 to 70 fold. 
Mortality risk is highest for seizures that begin within 12 hours of birth 
(53%). Neonates whose seizure duration was 1 day had 7% risk of CP and 
11% had epilepsy on follow up. If seizures lasted for >3 days, the rate of CP 
and epilepsy were 46% and 40% respectively. 
 93% of neonates with extreme burst suppression activity in EEG have 
poor outcomes 52. 
 Normal findings on diffusion weighted imaging (DWI) MRI between 
2 and 18 days are associated with normal neuromotor outcome at 12 to 18 
months. Deep grey matter abnormalities detected early have the worse 
motor and cognitive outcomes. Neonates with abnormal DWI of basal 
ganglia within 10 days of a hypoxic insult was associated with a 93% risk of 
abnormal neuro developmental outcome on follow-up when assessed 
between 9 months to 5 years 52.  
Multi organ dysfunction 
The fetus copes with an asphyxia event by a number of protective 
reflexes to preserve function to vital organs. Less well-perfused tissues may 
be particularly vulnerable to hypoxic-ischemic injury. In term neonates with 
perinatal asphyxia, renal, neurologic, cardiac and lung dysfunction occurs in 
50%, 28%, 25% and 23% respectively53. The kidney appears to be most 
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vulnerable, followed by the brain and then the heart. Gastrointestinal 
complications of asphyxia are uncommon (Table 5). 
Table 5.Multiorgan systemic effects of asphyxia 54 
 
General aspects of pathophysiology of hypoxia-ischemia 
Cell damage 
When a cell is exposed to hypoxia, the degree and duration 
determines the severity of injury. If hypoxia is brief, there is reversible 
cellular injury and if severe, the cell will be irreversibly damaged. Cell 
death can occur either due to necrosis or apoptosis. Necrosis occurs after 
loss of blood supply to the cell, but also seen when the cell is exposed to 
different toxins. Apoptosis is seen in both normal and pathological states 55. 
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The pathophysiological mechanisms of cell death are presented in Figure 1 
and 2. 
Fig. 1. The principle cellular and biochemical sites of damage in cell 
injury. Mitochondrial damage may lead to reversible injury and death 
by necrosis or apoptosis. [Adapted from Robbins Basic Pathology] 
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Fig. 2. Mechanism of cellular injury due to hypoxic insult. 
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Membrane injury 
 The mechanism of cellular membrane injury in HIE is multi factorial 
and not exclusively induced by the free radicals. Calcium influx activates 
phospholipases which has negative impact on the membrane phospholipids 
and proteases that will damage the cytoskeleton. If the integrity of cell 
membrane is lost, there will be irreversible damage with massive calcium 
influx and profound leakage of intracellular enzymes 55 (Fig. 3). 
Fig 3. Mechanisms of membrane damage in cell injury. [Adapted from 
Robbins Basic Pathology] 
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Specific aspects of Pathophysiology of perinatal asphyxia 
 Being born is stressful, particularly if it is by vaginal delivery. In 
normal delivery during each uterine contraction there will be transient fetal 
hypoxia 56, which results in the fetus becoming more acidemic as the labour 
progresses. In general, the greater the stress and trauma of labour, higher 
will be the catecholamine surge. Yet despite enduring this process for 
several hours, most neonates are pink, vigorous with regular breathing by 1-
2 minutes of age 57. Not all the babies make the transition to extrauterine 
environment without help. The action which we initiate in these babies in 
the first few minutes of life will make the difference between death, survival 
with cerebral palsy or intact neurological survival.  
 
Observed patterns of brain injury following hypoxia-ischaemia: 
Cerebral edema 
          Gross swelling of cerebral tissue with marked flattening and widening 
of gyri with obliteration of the sulci occurs within 24-48 hours of hypoxia, 
which is seen in imaging or at post mortem. It arises because of two 
mechanism, first one is cytotoxic, when membrane failure leads to 
intracellular fluid accumulation and second one is vasogenic, when the 
impaired blood brain barrier permits capillary leak and interstitial fluid 
accumulation 57. 
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Selective neuronal necrosis 
           The most common observed pathology after hypoxia is selective 
neuronal necrosis. The affected neurons appear in a scattered fashion and 
often widely distributed throughout the grey matter. The cerebral cortex 
layers 3 and 4 and the hippocampus are particularly vulnerable. This may 
reflect differing metabolic rates of the various cortical structures 57. 
Basal ganglia and brainstem 
         Basal ganglia injury seems to be responsible for the dyskinetic type of 
cerebral palsy seen in survivors of hypoxia and there may be abnormal 
signal intensity in basal ganglia on MRI. Abnormal capillary proliferation 
and microcalcification are seen in histology within first week. These are 
detected by ultrasound or CT imaging. An abnormal myelination pattern 
occurs if the infant survives for several months, which may be detected in 
MRI. Haemorrhage and haemorrhagic infarction affecting the thalamus are 
also a well recognized phenomenon 57. 
Parasagittal injury 
       This is an ischaemic injury affecting the cerebral cortex and subcortical 
white matter in vascular watersheds between the anterior, middle and 
posterior cerebral arteries, giving rise to a parasagittal distribution, and is 
often symmetrical 57. 
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White matter injury 
  In preterm infants periventricular leukomalacia occurs after hypoxic injury. 
In term infants subcortical leukomalacia occurs after ischaemic injury. The 
survivors of most severe insults show a mixed pattern of injury referred to 
as multi cystic leukoencephalopathy 57. 
Focal cerebral infarction 
        Infarction of major cerebral artery most commonly the left middle 
cerebral artery has been associated with asphyxia in the past, but it is now 
realized that this lesion occurs more commonly in infants with no evidence  
of intrapartum asphyxia (67%) 58. 
Laboratory evaluation of asphyxia :  
Cardiac evaluation  
• Cardiac troponin I and cardiac troponin T : 
These are the Cardiac regulatory proteins which control the calcium 
mediated interaction of actin and myosinare markers of myocardial damage. 
In asphyxiated neonates these protein levels are elevated.  
•  More than 5-10% of asphyxiated neonates have elevated serum 
creatine kinase myocardial bound (CK MB), which indicates 
myocardial injury. 
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Neurological markers of brain injury: 
• In asphyxiated neonates mostly within 12 hrs of the insult, serum      
CK MB may be increased but it has not been associated with long 
term neurological outcome. Also other serum markers like protein 
S-100, neuron specific enolase and urine markers have been 
measured. 
• Serum and urine markers of brain injury are not routinely used for 
predicting outcome or the presence of brain injury. 
Renal evaluation: 
• Serum creatinine and blood urea levels may be elevated in 
neonatal asphyxia especially within 2-4 days of insult. 
• Renal insult may also be confirmed with the help of Fractional 
excretion of sodium. 
• Proximal tubular dysfunction may be indicted by urine levels of         
β -2- microglobulin but not routinely used. This low molecular 
weight protein is freely filtered through the glomerulus and 
reabsorbed almost completely in the proximal tubule. 
• Renal sonographic abnormalities correlate with the occurrence of 
oliguria. 
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Brain imaging : 
Cranial ultrasound and Doppler cerebral blood flow: 
There are little data to support the use of this modality in the imaging 
of encephalopathy. However anterior and middle cerebral artery blood flow 
indices are helpful when measured within 6-24 hrs of age. (Pourcelot’s 
resistive index (PRI) < 0.50-0.60 is suggestive of poor neuro developmental 
outcome. This is a ratio of end – diastolic flow vs systolic blood flow. This 
index has a positive predictive value of 80% and is indicative of cerebral 
vascular, paralysis or impairment of cerebral auto-regulatory mechanisms59. 
Computed tomography: 
May be used to detect cerebral edema, hemorrhage and hypoxic 
ischaemic brain injury. However CT can be performed rapidly and done 
without sedation but has significant radiation effects. CT can be done only if 
MRI is unavailable or the baby is too unstable for MRI. 
MRI: 
          Types of MRI are as follows: 
• Conventional T1weighted and T2 weighted imaging 
• Diffusion weighted imaging  
• Proton MRS ( Magnetic Resonance Spectroscopy)  
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Conventional MRI: 
Three patterns of injury are most characteristically described in 
conventional MRI done between 2-8 days of age 
- Thalamus or posterior lateral putamen ( most severe and most 
common lesion ) 
- Parasagital grey and subcentral  white matter 
- Focal or multifocal brain injury 
T1 MRI images show hyperintense signals in less than three days lesion and 
T2 MRI images show hypointense signals by 6-7 days of life. 
Diffusion weighted imaging: 
 It provides evidence of cerebral injury before conventional MRI can 
pick up. However DWI imaging can be falsely negative if done earlier than 
24 hrs and later than 8 days. 
Proton MRS: 
This exciting modality provides additional prognostic data by 
studying the tissue concentration spikes of various metabolites. This 
modality can play an important role in the assessment of HIE and also can 
determine the age of the lesion. 
Management: 
It is important to realize that whatever damage is done cannot be 
reversed as at present there is no specific molecule ready for therapy in HIE. 
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Therefore the current standard of management of neonates with HIE has 
been limited to supportive therapy only. 
The Investigation and Management Principles are elucidated here: 
• Effective Neonatal Resuscitation (as per NRP by AAP / AHA)60 
• Respiratory management including ventilation for apnea / 
hypoventilation (in hypercarbia> 55 mm) or associated respiratory 
co-morbid conditions like meconium aspiration syndrome (MAS), 
persistent pulmonary hypertension in newborn (PPHN), atelectasis. 
• Correction of hemodynamic processes and maintenance of normal 
mean BP > 40 mm by use of volume and / or inotropes support as 
applicable.  
• Traditional fluid management has been to restrict fluids for first 48 – 
72 hrs in view of possibility of SIADH. Strict input and output 
charts, serum lactate, daily weights, serum and urinary electrolytes, 
urine output and urine specific gravity are used to manage a tight 
fluid balance. The goal is to aim for zero fluid balance. 
• Empirical antibiotics (Avoidance of aminoglycosides – nephrotoxic )  
• Correction of metabolic abnormalities is important. Common 
metabolic issues like  
- Hypoglycemia, hyperglycemia 
- Hypocalemia 
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- Hypomagnesemia 
- Hypo and hypernatremia 
- Hypo and hyperkalemia 
• Controlling seizures with anti seizures medication.  Definitely 
consider therapy if cardio respiratory status is compromised. 
• Correction of coagulopathy by FFP or specific factors as applicable.  
• Important to note that there is no role for use of steroids in HIE 
therapy. 
• Assessment of end organ damage  
- LIVER : liver failure ( increased Aspartate amino transferase , 
Alanine amino transferase , Gamma glutamyltransferase ) 
- KIDNEY: renal failure (anuria/ oliguria / creatinine.125 mmol /L ) 
- CARDIAC : cardiac dysfunction (inotropes > 4 hrs , increased 
level of troponin) 
 The appropriate management is dictated by the assessment of specific 
organ system. 
 The overall guiding principle / goal in management of HIE is to 
achieve normal hemostasis with maximum prevention of further injury as 
much as possible. 
 Perinatal asphyxia is a perilous condition due to its potential in 
causing severe damage even death of a newborn infant. The values of 
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present biochemical markers in diagnosing asphyxia is inadequate and 
controversial 21.  Uric acid is the end product of purine metabolism in 
humans 61. It is obtained from either increased breakdown of tissue nucleic 
acids or from increased turnover of purines. Xanthine oxidase and 
dehydrogenase are the enzymes that reduce the purines, xanthine and 
hypoxanthine to uric acid. Uric acid and reduced nicotinamide adenine 
dinucleotide are produced by Xanthine dehydrogenase. Xanthine oxidase 
produces uric acid and superoxide. In hypoxia or ischemia, the 
dehydrogenase form is increasingly converted to oxidized form. Uric acid 
has poor solubility that needs continuous excretion by the kidneys so as to 
avoid accumulation of toxic metabolites. The nature of its poor solubility 
tends to produce high serum levels when its production or excretion is 
altered.62,63 
 Uric acid excretion has four components; glomerular filteration, 
reabsorption, tubular secretion and reabsorption beyond secretory sites. 
Increased elimination of uric acid may be caused by metabolic changes, 
reflecting cellular hypoxia or changes in renal system. During 
reoxygenation and reperfusion after asphyxia and ischaemia, hypoxanthine 
accumulated in both circulating blood and tissues is oxidised to uric acid 64. 
Since urinary creatinine can be used as the reference substrate in a spot 
urine sample, an increased uric acid to creatinine ratio may be an absolute  
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indicator of severity of tissue hypoxia in patients with intact renal 
functions65. 
The ratio of urinary uric acid to creatinine helps in rapidly 
recognizing asphyxia and assessing its severity. Though numerous 
indicators for asphyxia are available, no single indicator has been found to 
be effective in predicting subsequent morbitity. The Apgar scores have been 
used long time since in defining asphyxia and in determing the outcome 
prognostication 66. Although many biochemical indicators such as , 
hypoxanthine, lactate, brain isoenzyme of creatinine phosphokinase, 
erythropoietin, neuron specific enolase, vasopressin and excitatory amino 
acids are reported ,they are most useful for the purpose of research and still 
remain unavailable in most clinical services 67. 
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MATERIALS AND METHODS 
Study design 
 This is an analytical cross sectional study.  
Study area 
 Neonatal Intensive Care unit of Paediatrics department, Government 
Rajah Mirasdar Hospital, Thanjavur. 
Study population 
 Case and control group compromised of asphyxiated and non 
asphyxiated neonates respectively. 
The case group: It included 50 neonates fulfilling the following criteria: 
Inclusion criteria: 
1) Gestational age ≥ 37 weeks. 
2) Appropriate for gestational age. 
3) The neonates will be identified to have experienced perinatal asphyxia 
when at least 3 of the following are present: 
A. Intrapartum signs of fetal distress, as indicated by non reassuring 
NST on continuous electronic fetal monitoring and/or by thick 
meconium staining of the amniotic fluid. 
B. Apgar score of < 7 at one minute of life 
C. Resuscitation with >1 minute of positive pressure ventilation 
before stable spontaneous respiration. 
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D. Umbilical arterial blood gas analysis showing pH <7.20. 
E. Mild, moderate or severe hypoxic ischemic encephalopathy 
(HIE), as defined by Sarnat and Sarnat staging in 1976 44. 
Exclusion Criteria: 
1. Congenital malformations. 
2. Maternal drug addiction. 
3. Neonates born to mothers who received magnesium sulphate within 
4 hours prior to delivery or opioids (pharmacological depression). 
4. Hemolytic disease of the newborn. 
5. Neonates born to mothers who consume alcohol 
6. Neonates born to mothers who are smokers 
7. Neonates born to mothers on anti epileptics 
 
The control group: 
 It included 50 term apparently healthy neonates appropriate for 
gestational age without signs of peinatal asphyxia as evidenced by normal 
fetal heart rate patterns, clear liquor and one minute Apgar score ≥7. 
All neonates included in the study had the following done: 
1)  Detailed maternal history, assessment of intrauterine fetal well being 
by continuous electronic fetal monitoring, meconium staining of 
amniotic fluid, mode of delivery, Apgar score, sex of the baby and 
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weight of the baby were recorded on the precoded proforma. 
Gestational age was assessed by New Ballard scoring system. Arterial 
blood gas analysis (ABG) was done in umbilical arterial blood in all 
neonates in case group. 
2) Thorough clinical and neurological examination was done for all the 
neonates included in the study. The asphyxiated neonates (case group) 
were monitored for seizures, hypotonia and HIE in the immediate 
neonatal period in the NICU. Grading system used to grade the 
severity of HIE was Sarnat and Sarnat staging in 197644. 
3) The case group also had other investigation done to rule out other 
causes of hypotonia, seizures, lethargy other than HIE with relevant 
investigations like blood glucose, serum electrolytes, blood culture and 
sensitivity. Peripheral smear study for erythrocyte morphology and 
reticulocyte count was done to document hemolytic disease of new 
born. 
Study Period 
From January 2016 t o July 2016. 
Sampling Procedure 
 Consecutive sampling 
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Sample size 
           50 asphyxiated neonates are included in case group and 50 non 
asphyxiated neonates are included in control group. 
Investigations done 
Urine samples were collected from the neonates and sent for urinary 
uric acid and creatinine ratio.The spot urine samples were collected between 
6-24 hours of life by catheterization or by attachment of urine collection 
bags. If there was any delay in analysis it was frozen at (- 20°C) until 
analysis could be carried out. Uric acid and creatinine in the same urine 
sample were determined by auto analyzer.
 
Uric acid 
Urine samples were analyzed on the autoanalyzer with automatic 
sample dilution using 0.9 NaCl. Assay principle: Enzymatic colorimetric 
assay using uricase was done. 
 
 The intensity of the red color was proportional to the uric acid 
concentration and was measured photometrically 68. 
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Creatinine 
 Urine samples were analyzed on the autoanalyzer with automatic 
sample dilution using 0.9NaCl. Assay principle:  Kinetic colorimetric assay 
(Jaffe Method) as follows: 
Creatinine +picric acid = creatinine-picric acid complex. 
 In an alkaline media, creatinine forms a yellow orange complex with 
picrate. The color intensity was proportional to the creatinine concentration 
and was measured photometrically69. 
Statistical Methods: Descriptive statistical analysis has been carried out in 
the present study. Results on continuous measurements are presented on 
Mean±SE (Min-Max) and results on categorical measurements are 
presented in proportions (%). Significance is assessed at 5% level of 
significance. 
 Analysis of variance (ANOVA) has been used to find the difference 
in study parameters between three or more groups of patients. Chi-square/ 
Pearson correlation has been used to find the difference in study 
parameters. 
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OBSERVATION AND RESULTS 
 
The present study was conducted in Neonatal Intensive care unit of 
Department of Paediatrics, Rajah Mirasdar Hospital, Thanjavur from 
January 2016 to July 2016. Cases and Controls comprised of asphyxiated 
and non-asphyxiated neonates, respectively. 
 
                   Table 6: Gender distribution of neonates studied 
 
 
Gender               Cases  Control 
 
No 
 
% 
 
No 
 
% 
Male  28 
 
56.0 
 
29 
 
58.0 
 
Female 
 
22 44.0 
 
21 
 
42.0 
 
Total 
 
50 
 
100.0 
 
50 
 
100.0 
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Fig. 4. Gender distribution of neonates studied
Male
Female
48 
 
The gender distribution of neonates is shown in Table 6 and Fig 4. 
Among the 50 neonates in case group, there were 2 8 (56%) males and 22 
(44%) females. Among the control group of 50 neonates, there were 29 
(58%) males and 21 (42%) females. Samples are gender matched with 
p=0.840 
Table 7: Gestational age of neonates studied 
Gestational age 
         (in weeks) 
              Cases  Control 
 
No 
 
% 
 
No 
 
% 
   (37-40 weeks) 40 80.0 50     100.0 
 
   (40-42 weeks) 10 20.0 0 0.0 
 
Total- 
 
50 
 
100.0 
 
50 
 
100.0 
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Fig. 5. Gestational age distribution of neonaates 
studied
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 The gestational age of neonates is shown in Table 7 and Fig. 5. 
Among 50 asphyxiated neonates who formed the case group 40 (80%) were 
in gestational age of 37-40 weeks, 10 (20%) were in gestational age of        
40-42 weeks. In control, all 50 neonates were below 40 weeks of gestation 
only. The gestational age distribution is statistically similar with p=0.001.   
Table 8: Birth weight of neonates studied 
 
BW (kg) 
            Cases         Controls 
No % No % 
2.50-3.00 36 72.0 39 78.0 
3.00-3.50 9 18.0 9 18.0 
3.50-4.00 5 10.0 1 2.0 
>4.00 0 0.0 1 2.0 
Total 50    100.0 50 100.0 
Mean ± SD 2.88±0.39 2.83±0.37 
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Fig. 6. Birth weight distribution of neonates studied
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The birth weight of neonates is shown in Table 8 and Fig. 6. Out of 
the 50 neonates incase group, 36(72%) neonates weighed between                
2.5-3.0kg, 9(18%) weighed between of 3.0-3.5kg and 5(10%) weighed 
b e t w e e n  3 . 5 - 4 0  kg.  None of the neonates weighed > 4 kg.  Among 
the control group of 50 neonates, 39 (78%) neonates weighed between          
2.5-3.0 kg, 9 (18%) weighed between 3.0-3.5kg, 1 (2%) weighed between 
3.5-4.0 kg and 1 (2.0%) weighed > 4 kg. The mean weight incase group was 
2.88±0.39 kg and in control group was 2.83±0.37 kg. Birth weight 
distribution is statistically similar with P=0.285.  
 
Table 9: Maternal parity of neonates studied 
 
 
Maternal 
Parity 
 
              Cases 
 
         Controls 
 
No 
 
% 
 
No 
 
% 
 
Primi 
 
26 52.0 22 44.0 
 
Multi 24 48.0 28 56.0 
 
Total 
 
50 
 
100.0 
 
50 
 
100.0 
 
 
 
51 
 
 
 
 
 
The maternal parity of neonates is shown in Table 9 and Fig. 7. Out 
of the 50 neonates in case group, 26 (52%) were born to primi mothers and 
24 (48%) were born to multi gravida mothers. Among the control group of 
50 neonates, 22 (44%) were born to primi mothers and 28 (56%) were born 
to multi gravid mothers. Proportion of primi and multi gravid mothers are 
statistically similar with P=0.423. 
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Fig. 7. Shows the maternal parity of neonates studied
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     Table10: Mode of delivery of neonates studied 
 
 
Mode of delivery 
 
Cases 
 
Controls 
 
No 
 
% 
 
No 
 
% 
 
Normal     33 66.0 48 96.0 
 
 
Instrumental 2 4.0     0 
 
     0.0 
 
LSCS 15 30.0 2 4.0 
 
Total 
 
50 
 
100.0 
 
50 
 
 100.00 
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Fig. 8.  Mode of delivery of neonates studied
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The mode of delivery of neonates is shown in Table 10 and Fig. 8. Among 
the 50 neonates in case group, 33 (66%) neonates were delivered normally,          
15 (30%) were delivered by cesarean section and 2 (4%) neonates through 
instrumental delivery. While in control group of the 50 neonates, 48 (96%) 
were delivered normally, 2 (4%) neonates were delivered by cesarean 
section and none of the neonates was born by instrumental delivery. The 
Incidence of cesarean section and instrumental delivery are significantly 
more in cases (34%) compared to controls (4%) with P=0.001. 
 
 
 
Table 11: Signs of Fetal Distress of neonates studied 
 
 
 
NST 
FD 
Cases 
 
 
Controls 
 
 
No % No % 
Reactive 7 14.0 50 100.0 
Non-reactive 43 86.0 0 0.0 
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The signs of fetal distress of neonates are shown in Table 11 and          
Fig. 9. Of the 50 neonates in case group, 7 (14%) had Reassuring NST and 
43 (86%) had Non Reassuring NST suggestive of fetal distress. All the 50 
(100%) neonates in control group had Reassuring NST. The Incidence of 
Non Reassuring NST is significantly more in cases (86%) against controls 
with P< 0.001. 
       Table 12: Thick Meconium Stained Amniotic Fluid (TMSAF)status 
of the neonates studied 
  
TMSAF 
 
Cases Controls 
No % No % 
Negative 30 60.0 50 100 
Positive 20 40.0 0        0.0 
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Fig. 9. Maternal non stress test (NST) of the neonates 
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Of the 50 neonates in case group, 20 (40%) had Thick MSAF and 30 
(60%) had clear amniotic fluid. All the 50 (100%) neonates in control 
group had clear amniotic fluid (Table 12 and Fig.10). The Incidence 
of Thick MSAF is significantly more in cases against controls with               
P< 0.00I. 
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Table 13: Apgar score of neonates studied at 1, 5 and 10 min 
 
 
 
Apgar score 
 
              Cases 
 
       Controls 
 
No 
 
% 
 
No 
 
% 
 
At 1minute 
 
<7 
 
50 
 
  100.0 
 
    0      0.0 
 
         >7 
 
0 
 
0.0 
 
   50 
 
     100.0 
 
At 5minutes 
 
<7         18 36.0     0 
 
0.0 
 
>7         32 64.0     50 
 
100.0 
 
At 10minutes 
 
<7          9 18        0 
 
0.0 
 
>7 41 82        50 
 
100.0 
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Fig. 11a. Showing the APGAR score at 5 minutes of the 
neonates studied
<7
>7
57 
 
Of the 50 neonates in case group, 18 (36%) neonates had an Apgar 
score of <7 at 5 min and 32 (64%) had Apgar score above 7. All the 50 
(100%) neonates in the control group had an Apgar score of ≥7.0 (Table 13 
and Fig. 11a).  
 
 
 Among the 50 neonates in case group, 9 (18%) neonates had an Apgar 
score of <7at10 min and 41 (82%) had above 7 Apgar score. All the 
50(100%) neonates in the control group had an Apgar score of ≥7.0 (Table 
13 and Fig. 11b). 
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Table 14: Severity of HIE based on Apgar score of neonates studied 
 
 
 
Apgar score 
 
Cases (n=50) 
 
Controls (n=50) 
 
    No 
 
% 
 
No 
 
% 
 
Apgar score at 1 min 
 
0-3 31 62.0 0 0.0 
 
4-6 19 38.0 0 0.0 
 
≥7.0 0 0.0 50  100.0 
 
Apgar score at 5 min 
 
0-3 2 4.0 0 0.0 
 
4-6 16 32.0 0 0.0 
 
≥7.0 32 64.0 50  100.0 
 
Apgar score at 10 min 
 
0-3 0 0.0 0 0.0 
 
4-6 9 18.0 0 0.0 
 
≥7.0 41 82.0 50   100.0 
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The severity of HIE based on Apgar score of neonates studied is 
shown in Table 14. Of the 50 neonates in the case group, 31 (62%) neonates 
had an Apgar score between  0-3 (severe birth asphyxia) at 1 min, 19 (38%) 
had an Apgar score  between 4-6 (Moderate birth asphyxia)  and none of 
the neonates had an Apgar score of  ≥ 7 at 1 min. Of the 50 neonates in case 
group, 2 (4%) neonates had an Apgar scores between 0-3 (severe birth 
asphyxia) at 5 min, 16 (32%) neonates had an Apgar score between 4-6 
(moderate birth asphyxia) at 5 min and a majority of 32 (64%) neonates had 
an Apgar score of ≥ 7 at 5 min. Out of 50 neonates in case group, 9 (18%) 
neonates had an Apgar score between 4-6  (moderate birth asphyxia) at 10 
min, 41 (82%) had an Apgar score of  ≥ 7 and none had an Apgar score 
between 0-3 (severe birth asphyxia) at 10 min. 
 
Table 15: Resuscitation with >1 minute of positive pressure 
ventilation required for the neonates studied 
 
 
 
Resuscitation 
 
            Cases 
 
        Controls 
 
No 
 
% 
 
No 
 
% 
 
Negative 
 
0 
 
0.0 
 
50 
 
100.0 
 
Positive 
 
50 
 
100.0 
 
0 
 
0.0 
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The resuscitation with >1 minute of positive pressure ventilation 
required is shown in Table 15 and Fig. 12. Among the 50 neonates in case 
group, all the 50(100%) neonates were in need of resuscitation 
with>1minute of positive pressure ventilation before stable spontaneous 
respiration. All the50 (100%) neonates in control group were not
 in need 
of any such intervention (100.0%) with p=0.002. 
   Table 16: Showing the arterial pH of the neonates studied 
          ABG No of patients (n=50) % 
7.10-7.15 4 8.0 
7.15-7.20 6       12.0 
7.20-7.25 13 26.0 
7.25-7.30 17 34.0 
7.30-7.35 7 14.0 
7.35-7.40 2 4.0 
7.40-7.45 1 2.0 
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Fig. 12. Showing the need for resuscitation 
with >1 min of PPV of the neonates studied
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The arterial pH of the neonates is shown in Table 16 and Fig. 13. 
Among the 50 cases of neonatal asphyxia studied 4(8%) of the neonates 
had arterial pH between7.10-7.15, 6 (12%) of the neonates had arterial pH 
between 7.15-7.2, 13 (26%) of the neonates had arterial pH between 7.2-
7.25, 17 (34%) of the neonates had arterial pH between 7.25-7.3, 7 (14%) 
of the neonates had arterial pH between7.3-7.35,  2(4%)  of  the  neonates  
had  arterial  pH  between  7.35-7.4  and 1 (2%)  of  the neonates had 
arterial pH between 7.4-7.45. 
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Fig. 13. Showing the arterial pH of the neonates
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Table 17: Neurological Examination of the neonates studied 
 
Tone 
 
No of patients (n=50) 
 
% 
 
Normal 
 
  27       54.0 
 
Decreased 
 
                  20       40.0 
 
Flaccid 
 
                  3 
 
      6.0 
 
 The tone of the neonates is shown in Table 17 and Fig14. Out of the 
50 neonates in case group, 27 (54%) had normal tone, 20 (40%) had  
hypotonia and 3 (6%) were flaccid. In control cases, 50 (100%) neonates 
had normal neurological examination. Abnormal neurological examination 
is significantly more (46%) in cases compared to controls with p<0.001. 
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Fig. 14. Tone of neonates studied
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Table 18: Neonates having seizures in this study 
 
Seizures 
 
No of patients (n=50) 
 
% 
 
Negative 
 
27 54.0 
Positive 23 46.0 
 
 
Of the 50 neonates in case group, 27 (54%) had no seizures, 23 (46%) had 
seizures (Table 18 and Fig. 15). Seizures are significantly more (46%) in 
cases compared to controls with p<0.001. 
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Table 19: Incidence of HIE (Hypoxic Ischemic Encephalopathy) 
among neonates studied 
 
 
HIE 
 
No of patients (n=50) 
 
% 
 
Not in HIE 
 
10 20 
 
Stage I 
 
18 36 
 
Stage II 
 
17 34 
 
Stage III 
 
5 10 
Stages classified as per Sarnat and Sarnat classification of hypoxic 
ischemic encephalopathy 1976. 
 
The incidence of HIE among neonates is shown in Table 19 and 
Fig.16. Among the 50 neonates in the case group, 10(20%) were not in HIE, 
18(36%) had mild HIE, 17(34%) had moderate HIE and 5(10%) had severe 
HIE in the immediate neonatal period in the Neonatal Intensive Care Unit.
 
0
5
10
15
20
25
30
35
40
Not in HIE Stage I Stage II Stage III
Pe
rc
en
ta
ge
HIE
Fig. 16. Showing HIE staging of asphyxiated 
neonates
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Table 20. Outcome of neonates in the case group (Asphyxiated) 
Outcome No. of patients (n=50) % 
Discharge 46 92% 
Death 4 8.0% 
 
 
The outcome of neonates enrolled in the case group having suffered 
asphyxia is shown in Table 20 and Fig. 17. Among the 50 neonates enrolled 
in the case group, 46 (92%) neonates were discharged and 4 (8%) died. 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
Discharge Death
Pe
rc
en
ta
ge
Outcome
Fig. 17. Outcome of neonates in the case group
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Table 21: Comparison of Urinary uric acid/creatinine (UUA/Cr) ratio 
in two groups studied 
 
 
UUA/Cr 
 
         Cases 
 
Controls 
 
Min-Max 
 
0.78-4.74 0.42-1.23  
 
Mean ± SD 
 
2.59±1.04 
 
0.72±0.16 
 
 
Inference 
 
UUA/Cr ratio is significantly higher in study 
group compared to Control with P<0.001 
 
 
The comparison of UUA/Cr ratio in two groups studied is shown in 
Table 21 and Fig. 18. UUA/Cr ratio is significantly higher in study group 
compared to Control with P<0.001. 
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Fig. 18. Comparison of Urinary uric acid/creatinine 
(UUA/Cr) ratio in two groups studied
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Table 22: Correlation of urinary uric acid and creatinine ratio 
(UUA/Cr) with HIE status in cases studied 
 
 
UUA/Cr 
Total number 
of patients 
(n=50) 
HIE Stage  
 
 
 
 
P value 
 
Not in 
HIE 
(n=1) 
 
Stage I 
(n=18) 
 
Stage II 
(n=17) 
 
Stage III 
(n=5) 
 
Min-Max 
 
0.78-4.74 
 
0.78-2.65 
 
1.62-3.48 
 
1.11-3.92 
 
3.52-4.74  
 
<0.001** 
 
Mean ± SD 
 
2.59±1.04 
 
1.28±0.53 
 
2.66±0.70 
 
2.79±0.74 
 
4.29±0.46 
 
 
 
 
 Table 22 and Fig. 19 showed the correlation of UUA/Cr ratio with 
HIE status in cases studied and it was found to be statistically significant 
with the p value of < 0.001. 
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Fig. 19. Comparison of UUA/Cr raatio with HIE 
status in cases studied
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Table 23. Diagnostic value of UUA/Cr ratio 
Variables Values 
True positive 43 
True Negative 46 
False Positive 4 
False Negative 7 
Sensitivity 86% 
Specificity 92% 
PPV 91.49% 
NPV 86.49% 
Accuracy 89% 
 
PPV-Positive predictive value, NPV-Negative predictive value 
 Table 24: Shows sensitivity, specificity and predictive values of  
UUA/Cr in prediction of Neonatal asphyxia 
 
 
UUA/Cr 
 
 
Sensitivity 
 
 
Specificity 
 
 
PPV 
 
 
NPV 
 
 
Accuracy 
 
 
P value 
 
>1.22 
 
86.0 
 
92.0 
 
91.49 
 
86.49 
 
89.00 
 
<0.001** 
 
  The sensitivity, specificity and predictive values of UUA/Cr in 
prediction of Neonatal asphyxia is shown in Table 24. 
 Urinary UA/Cr value of >1.22 has 86% sensitivity, 92% specificity, 
positive predictive value of 91.49%, negative predictive value of 86.49% 
and an accuracy of 89% in diagnosing asphyxia among term neonates. 
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                                                DISCUSSION 
 
 Perinatal asphyxia is a common neonatal condition contributing 
significantly to neonatal morbidity and mortality. Although asphyxia is a 
commonly made diagnosis at birth there is no accepted definition. It is a 
devastating condition because of its potential to cause permanent damage 
and even death of the neonate. The value of biochemical markers for 
diagnosing asphyxia is inadequate and controversial 21. Many studies have 
shown cerebral function monitoring using EEG, cranial ultrasonography, 
MRI and estimation of markers such as CK-BB, brain specific LDH isomer 
glutamide and neuron specific enolase in CSF are useful in predicting both 
the immediate dysfunction and the long term outcome 70, 71, but they are not 
easily available. Due to limitations, the Apgar score cannot be used as an 
useful tool for the evaluation of asphyxia in newborns. Various factors 
especially prematurity has an effect on it as a result of which it may not 
predict mortality and morbidity definitely. The signs of asphyxial injury are 
nonspecific and overlap with other illnesses. In the absence of perinatal 
records, it is difficult to diagnose neonatal asphyxia retrospectively. The 
current problem is our inability to precisely distinguish the false positively 
diagnosed from the true positive asphyxiated neonates. Several studies have 
been conducted to evaluate better markers which would help to differentiate 
asphyxiated and non-asphyxiated neonates. 
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In our study an attempt is made to ascertain whether UUA/Cr ratio can 
distinguish an asphyxiated from Non-asphyxiated term neonate. These tests 
are routinely available in most centers and hence the study was done to 
establish its usefulness. 
          Uric acid is the end product of purine metabolism in humans. Under 
certain conditions like hypoxia or ischaemia, there will be increased 
conversion of the Xanthine dehydrogenase to the oxidized form. Because of 
its poor solubility, any alterations in production or excretion will produce 
high serum levels 62, 63. During reoxygenation after asphyxia or reperfusion 
after ischemia, hypoxanthine that accumulated in both circulating blood and 
tissues is oxidized to uric acid 64.  
      The present study showed significant increase in UA/Cr ratio in early 
urine samples from asphyxiated full term neonates and the study revealed 
positive correlation between the UA/Cr ratio and the severity of HIE. 
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Table 25: Comparison of gender, birth weight and UUA/Cr ratio 
between our study and  Reem Mahmoud and Dina El Abd study20 
 
 
Characteristics 
 
 
Reem Mahmoud and Dina 
EI Abd 
 
 
Present study 
 
 
P value 
Cases Controls Cases Controls  
 
Sex 
 
Male 
 
40% 
 
70% 
 
56% 
 
58% 
 
 Not 
significant Female 60% 30% 44% 42% 
 
Birth weight 
 
3.25±0.54kg 
 
3.32±0.44kg 
 
2.88±0.39kg 
 
2.83±0.37 kg 
Not 
significant 
 
UUA/Cr ratio 
 
2.9±0.73 
 
0.72 ±0.35 
 
2.59±1.04 
 
0.72±0.16 
 
<0.001 
 
UUA/Cr ratio was significantly elevated in asphyxiated neonates 
when compared with controls (p<0.001) in Reem Mahmoud and Dina El 
Abd study which was similar to the findings in our study (Table 25). 
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Table 26: Comparison of UUA/Cr ratio in various HIE stages of 
Reem Mahmoud and Dina EI Abd20 study and present study 
UUA/Cr Reem Mahmoud and 
Dinaa EI Abd20 
 Present study 
Mild HIE 
Min-Max 1.02-2.11 1.62-3.48 
Mean ± SD 1.53±0.25 2.66±0.70 
Moderate HIE 
Min-Max 1.68-2.69 1.11-3.92 
Mean ± SD 2.19±0.32 2.79±0.74 
Severe HIE 
Min-Max 2.25-4.54 3.52-4.74 
Mean ± SD 3.18±0.61 4.29±0.46 
Controls 
Min-Max 0.20-1.22 0.42-1.23 
Mean ± SD 0.72±0.35 0.72±0.16 
Asphyxiated neonates were classified into 3 groups as per                  
Sarnat and Sarnat staging 1976 in both the studies. 
The highest UA/Cr ratio was found in severe HIE in our study which 
is similar to Reem Mahmoud and Dina EI Abd study (Table 26). 
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Table27. Comparative study of UUA/Cr ratio between our study and 
Basu et al13, Bader et al17 
Characteristics Basu et al Bader et al Present study P 
value Cases 
(n=31) 
Controls 
(n=31) 
Cases 
(n=18) 
Controls 
(n=50) 
Cases 
(n=50) 
Controls 
(n=50) 
 
UUA/Cr ratio 
 
3.1±1.3 
 
0.96±0.54 
 
2.06±1.12 
 
0.64±0.48 
 
 
2.59±1.04 
 
 
0.72±0.16 
 
<0.001 
The urinary UA/Cr ratio was significantly higher in cases than controls in 
our study which is similar to Basu et al and Bader et al. 
Table 28: Comparative study of results of our study and Bader et al17 
 UUA/Cr 
cutoff 
Sensitivity Specificity PPV NPV P value 
Present 
study 
>1.22 86% 92% 91.49% 86.49% <0.001 
Bader et al >1.2 74% 76% 78% 72% <0.001 
 
The positive predictive value of UUA/Cr with a cut off > 1.2 in a 
study by Bader et al was 78% and the negative predictive value was 72%. 
The sensitivity was 74% and specificity 76% which was similar to our 
study. 
Ciler Erdag and Vitrinel reported that the mean uric acid and 
creatinine ratio within 24 hours of birth was more in asphyxiated neonates 
than non asphyxiated neonates 14. 
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            The results of present study were in concordance with Akisu et al   
(2007), who reported elevated UA/Cr ratio in full term infants with asphyxia 
and it correlated with the severity of HIE. The UA/Cr ratio was higher in 
asphyxiated neonates than non asphyxiated neonates (2.11±0.83 vs 
0.72±0.39 p< 0.001). The UA/Cr ratio was found to be a good, simple 
screening test for the early assessment of perinatal  asphyxia16 . 
Mehes et al72 reported that the UA/Cr ratio was elevated in term 
infants with asphyxia and the ratio correlates with the severity of HIE. They 
concluded that   UA/Cr ratio is a good and simple screening test for early 
assessment of perinatal asphyxia. 
      Dong Wen Bin, et al 19 reported in his study that asphyxiated neonates 
have higher UA/Cr ratio than non asphyxiated neonates. It might be used as 
an indicator for early assessment of severity of asphyxia and post asphyxia 
renal injuries. 
       Jensen et al 22 and Hasday and Grum23 found increased uric acid in 
urine of asphyxiated neonates. 
          The UA/Cr ratio allows rapid recognition of asphyxia and assessment 
of its severity. While many indicators for asphyxia are recognized, no single 
indicator was found to be predictive of subsequent morbidity. Although 
several biochemical indicators such as lactate, hypoxanthine,brain 
isoenzyme of creatinine phosphokinase, neuron specific enolase, excitatory 
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amino acids and erythropoietin are reported, they are mostly useful in 
research and are not available in most clinical services 67. 
       However, we found that the urinary uric acid to creatinine ratio to be a 
good, simple screening test for the early assessment of neonatal asphyxia. 
Furthermore there is correlation between the UUA/Cr ratio and the severity 
of the encephalopathy, indicating the degree of injury at early stage when 
other quantitative methods frequently cannot be carried out. However, this 
ratio does not provide further prognostic information that must be obtained 
by other methods. 
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SUMMARY 
 
 
 This is an analytical cross sectional study conducted from January 
2016 to July 2016 in the Department of Pediatrics, Rajah Mirasdar 
Hospital, Thanjavur. 
 Cases and Controls comprised of asphyxiated and non asphyxiated 
neonates, respectively. The spot urine samples collected between 6-24 
hours of life and sent for urinary uric acid to creatinine ratio analysis 
constituted the material for the study. 
 A urinary uric acid to creatinine (UA/Cr) ratio value of >1.22 was 
taken as the cut-off level. The sensitivity, specificity, Positive 
predictive value (PPV), Negative predictive value (NPV) was 
calculated. 
 Among the 50 neonates in case group, there were 28 (56%) males and 
22 (44%) females. Among the control group of 50 neonates, there 
were 29 (58%) males and 21 (42%) females. Samples are gender 
matched with p=0.840 
 Among 50 asphyxiated neonates which formed the case group 
40(80%) cases were in gestational age of 37-40 weeks, 10 (20%) cases 
were in gestational age of 40-42 weeks, where as all normal neonates 
which constituted the control group were in gestational age of 37-40 
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weeks. The correlation with gestational age was found to be 
statistically significant with p value of 0.001. 
 Among the 50 neonates in case group 36(72%) neonates weighed 
between 2.5-3.0kg, 9(18%) weighed between 3.0 3.5kg and 5(10%) 
weighed>3.5kg. Among the control group of 50 neonates, 39(78%) 
neonates weighed between 2.5-3.0kg, 9(18%) weighed between3.0-3.5 
kg and 1 (2%) weighed between 3.5-4.0 kg, 1(2%) > 4kg. The mean 
weight in case group was 2.88±0.39 kg and in control group was 
2.83±0.37 kg. Birth weight distribution is statistically similar with 
P=0.285. 
 Among the 50 neonates in case group, 26(52%) were born to primi 
mothers and 24(48%) were born to multi gravida mothers. Among the 
control group of 50 neonates, 22 (44%) were born to primi mothers and 
28 (56%) were born to multi gravida mothers. The correlation with 
maternal parity was found to be statistically not significant with a p 
value of 0.840. 
 Among the 50 neonates in case group, 33(66%) neonates were 
delivered normally, 15(30%) were delivered by cesarean section and 
2(4%) had instrumental delivery. Among the control group of 50 
neonates, 48(96%) had normal delivery, 2 (4%) neonates were 
delivered by cesarean section. Incidence of cesarean section and 
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instrumental delivery are significantly more in cases compared to 
controls  with P=0.001 
 Of the 50 neonates in case group, 7(14%) had Reassuring NST and 43 
(86%) had Non Reassuring NST suggestive of fetal distress. All the 50 
(100%) neonates in control group had Reassuring NST. Incidence of 
Non Reassuring NST is significantly more in cases  (86%) against 
controls with P<0.001. 
 Of the 50 neonates in case group, 20(40%) had Thick MSAF and in 30 
(60%) the amniotic fluid was clear. All the 50(100%) neonates in t h e  
control group had clear amniotic fluid. Incidence of thick MSAF was 
significantly more in case group when compared to control group. 
 All the 50 neonates were in need of >1 minute of positive pressure 
ventilation before stable spontaneous respiration in the case group. All 
the 50 (100%) neonates in control group  were  not  in  need  of  any  
such  intervention   with  a P<0.001 
 Out of the 50 cases of neonatal asphyxia studied 4(8%) of the neonates 
had arterial pH between 7.10-7.15, 6(12%) of the neonates had arterial 
pH between 7.15-7.2, 13(26%) of the neonates had arterial pH 
between7.2-7.25, 17(34%) of the neonates had arterial pH between 
7.25-7.3, 7(14%) of the neonates had arterial pH between 7.3-7.35, 
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2(4%) of the neonates had arterial pH between 7.35-7.4, 1(2%) 
neonate had arterial pH between 7.4-7.45. 
 Of the 50 neonates in case group, 27(54%) had normal neurological 
examination with normal tone, 20(40%) had hypotonia and 3(6%) 
were flaccid. All the 50 (100%) neonates in control group had normal 
neurological examination. Abnormal neurological examination is 
significantly more (46.0%)   in cases when compared to controls with 
P<0.001. 
 Of the 50 neonates in case group, 27(54%) had no seizures. 23(46%) 
had seizures. Seizures are significantly more (46.0%) in case group 
when compared to control group with P<0.001. 
 Of the 50 neonates in the case group, 10(20%) were not in HIE, 
18(36%) had mild HIE, 17(34%) had moderate HIE and 5(10%) had 
severe HIE in the immediate neonatal period in Neonatal Intensive 
Care Unit. 
 Out of 50 asphyxiated neonates enrolled in the case group, 46(92%) 
were discharged after recovery while discharge, 4(8%) died.  
 UUA/Cr ratio is significantly higher in study group compared to 
Control with P<0.001. The correlation of urinary UA/Cr ratio with 
80 
 
HIE status was found to be statistically significant with a p value of 
<0.001. 
Urinary UA/Cr cut of value of >1.22 has 86% sensitivity,92% 
specificity, positive predictive value of 91.49%, negative predictive 
value of 86.49% and an accuracy of 89% in diagnosing asphyxia 
among term neonates. 
 
 
 
 
 
 
 
 
 
 
 
 
                                     
 
81 
 
 
 
 
 
 
CONCLUSION 
 
1. Urinary uric acid to creatinine ratio is higher in asphyxiated infants 
than non asphyxiated infants. 
2. Urinary uric acid to creatinine ratio can be used as a quick, 
inexpensive, non invasive, reliable, early biochemical marker of birth 
asphyxia. 
3. Estimation of urinary uric acid to creatinine ratio had good 
correlation with severity of HIE.  
4. This ratio does not provide further prognostic information which 
must be obtained by other biochemical markers or neuroimaging. 
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PROFORMA OF THE DISSERTATION 
STUDY OF URINARY URIC ACID / CREATININE RATIO AS A 
MARKER OF NEONATAL ASPHYXIA  
BABY OF  :      D.O.A.: 
SEX     :      D.O.D.:  
TIME AND  
DATE OF BIRTH : 
BIRTH WEIGHT : 
ASSESSMENT OF GESTATIONAL AGE : 
METHOD LMP USG 
NEW BALLARD 
SCORE 
PERIOD OF 
GESTATION 
   
 
MATERNAL HISTORY : 
NON STRESS TEST : REASSURING / NON REASSURING 
BIRTH NOTES  : 
THICK MECONIUM STAINED AMNIOTIC FLUID : YES / NO 
APGAR score 1 MIN 5 MIN 10 MIN 
 
EXAMINATION OF THE BABY : 
 
HEAD TO TOE EXAMINATION : 
 
 
 
 
ANY OBVIOUS EXTERNAL  
CONGENITAL ABNORMALITIES: 
NEUROLOGICAL EXAMINATION : 
OTHER SYSTEMIC EXAMINATION : 
COURSE IN NICU    : 
HIE STAGE     : 
INCLUSION CRITERIA YES NO 
1) Gestational age ≥ 37 weeks   
2) Appropriate for gestational age   
3) The neonates will be identified to haveexperienced 
perinatal asphyxia when at least 3of the following are present: 
  
A) Intrapartum signs of fetal distress, as indicated by late 
decelerations on fetal monitoring or by thick meconium 
staining ofthe amniotic fluid 
  
B) APGAR score of <7 at one minute of life   
C) RESUSCITATION with >1 minute of positive pressure 
ventilation before stable spontaneous respiration. 
  
D) Profound metabolic or mixed acidemia (pH<7.20) in an 
arteryblood sample, if obtained 
  
E) Mild, moderate or severe hypoxic ischemic 
encephalopathy (HIE), as defined by Sarnat & Sarnat, 1976 
  
 
 
 
 EXCLUSION CRITERIA YES NO 
1) Congenital malformations   
2) Maternal drug addiction   
3) Neonates born to mothers who would have received 
magnesium sulphate within 4 hours prior to delivery or 
opiods 
  
4) Congenital or acquired infections   
5) Hemolytic disease of the newborn   
6) Neonates born to mothers consuming alcohol   
7) Neonates born to mothers who are smokers   
8) Neonates born to mothers on anti epileptics.   
 
Investigations: 
 
1) Umbilical Artery Ph: 
 
      2) 
 
Markers Levels in urine sample 
a) uric acid  
b) creatinine  
 
3) Urinary Uric Acid And Creatinine Ratio : 
 MASTER CHART OF CASES 
SL. 
NO 
IPNO SEX GA BW MH MOD FD Apgar RES ABG NE HIE D UUA/CR 
       NST TMSAF 1’ 5, 10,       
1. 415389 M T 2.80 Kg  
AGA 
MG CS NR - 5/10 8/10 8/10 + 7.29 T N S- 1 
 
D 3.04 
2. 415391 Fch T 2.45 Kg  
AGA 
P ND NR - 1/10 6/10 7/10 + 7.21 T↓ S+ 2 D 1.92 
3. 415478 F T 2.6 0Kg  
AGA 
P CS NR - 5/10 8/10 8/10 + 7.28 T N S- 1 D 2.55 
4. 415646 F T 2.6 0Kg  
AGA 
P ND NR - 2/10 4/10 6/10 + 7.16 T↓ S+ 3 D 4.22 
5. 415663 F PD 3.78 Kg  
AGA 
MG ND NR - 5/10 7/10 9/10 + 7.30 T N S- 1 D 3.02 
6. 415738 F T 3.0 0Kg  
AGA 
MG CS NR - 1/10 6/10 7/10 + 7.21 T↓ S+ 2 D 3.92 
7. 415897 F T 3.12Kg  AGA P ND R + 5/10 9/10 9/10 + 7.34 T N S- - D 2.65 
8. 415912 F T 2.67 Kg  
AGA 
MG CS NR - 2/10 8/10 8/10 + 7.23 T↓ S+ 2 D 2.68 
9. 415928 F T 3.52 Kg  
AGA 
P CS NR - 3/10 8/10 9/10 + 7.45 T N S- 1 D 1.20 
10. 415948 M T 2.63 Kg  
AGA 
P ND NR - 1/10 4/10 6/10 + 7.14 T F S+ 3 D 3.52 
11. 417183 M T 2.6 0Kg  
AGA 
MG CS NR - 2/10 8/10 8/10 + 7.25 T N S- 1 D 3.48 
12. 417779 F T 2.80Kg AGA MG ND NR - 5/10 8/10 8/10 + 7.29 T N S- 1 D 3.14 
13. 417941 M PD 2.60Kg AGA P ND NR + 1/10 5/10 7/10 + 7.22 T↓ S+ 2 D 3.71 
14. 418665 M T 3.90Kg AGA MG ND NR - 1/10 8/10 8/10 + 7.28 T N S- 1 D 3.28 
15. 418870 M T 3.40Kg AGA MG ND NR - 1/10 4/10 6/10 + 7.20 T↓ S+ 2 D 2.80 
16. 413287 M T 3.00Kg AGA P ND NR + 4/10 8/10 8/10 + 7.20 T↓ S+ 2 D 2.87 
17. 418916 M T 2.5Kg AGA P CS NR - 1/10 3/10 5/10 + 7.10 T F S+ 3 Expired 4.74 
18. 419455 M T 2.90Kg AGA MG ND R - 2/10 6/10 6/10 + 7.22 T↓ S+ 2 D 2.88 
19. 419667 F PD` 3.10Kg AGA P ID NR + 1/10 7/10 9/10 + 7.26 T N S- 1 D 1.62 
20. 419245 F T 2.80Kg AGA MG ND NR - 5/10 8/10 8/10 + 7.29 T N S- 1 D 3.14 
21. 419954 M T 2.60Kg AGA MG ND NR - 4/10 8/10 8/10 + 7.20 T N S- - D 0.78 
22. 420015 M T 2.60Kg  AGA P ND NR + 5/10 8/10 8/10 + 7.28 T N S- 1 D 3.38 
23. 415692 N       T 2.50Kg  AGA P CS NR - 1/10 6/10 8/10 + 7.20 T↓ S+ 2 D 1.11 
24. 421007 M T 2.70Kg  AGA MG ND NR + 3/10 7/10 8/10 + 7.22 T↓ S+ 2 D 2.93 
25. 421305 M PD 2.60Kg  AGA MG ND NR - 3/10 8/10 8/10 + 7.21 T↓ S+ 2 Expired 3.82 
26. 421806 F PD 3.40Kg  AGA MG  ND R + 4/10 8/10 8/10 + 7.32 T N S- - D 1.32 
27. 413452 F T 2.70Kg  AGA P ND R - 2/10 4/10 6/10 + 7.24 T↓ S+ 2 D 2.18 
28. 430324 M T 2.50Kg  AGA P ND NR + 1/10 7/10 8/10 + 7.26 T N S- 1 D 3.32 
29. 430331 F T 2.40Kg  AGA MG ND NR + 1/10 5/10 6/10 + 7.14 T F S + 3 Expired 4.50 
30. 430401 M PD 2.55Kg  AGA MG ND NR - 3/10 8/10 8/10 + 7.21 T↓ S+ 2 D 3.82 
31. 430480 M T 2.50Kg  AGA P ND NR - 5/10 8/10 8/10 + 7.27 T N S- 1 D 3.06 
32. 430638 F T 2.90Kg  AGA P CS NR - 4/10 9/10 9/10 + 7.29 T N S- 1 D 2.90 
33. 431046 M T 3.20Kg  AGA MG CS NR + 3/10 8/10 9/10 + 7.26 T N S- 1 D 3.10 
34. 431134 F T 3.05Kg  AGA P CS NR + 4/10 8/10 8/10 + 7.29 T N S- 1 D 1.78 
35. 431284 F T 2.67Kg  AGA MG CS NR - 3/10 6/10 7/10 + 7.26 T N S- 1 D 2.10 
36. 431295 F PD 2.76Kg  AGA MG ND NR - 4/10 6/10 8/10 + 7.19 T↓ S+ 2 D 2.98 
37. 431591 F T 3.65Kg  AGA P ID NR + 1/10 8/10 8/10 + 7.31 T N S- 1 D 2.12 
38. 431607 M T 2.60Kg  AGA P ND R - 3/10 9/10 9/10 + 7.32 T N S- - D 1.32 
39. 431989 M T 2.76Kg  AGA MG CS NR - 5/10 6.10 7/10 + 7.30 T N S- - D 1.02 
40. 423477 M T 2.77Kg  AGA MG ND NR + 3/10 6/10 7/10 + 7.22 T↓ S+ 2 D 2.98 
41. 432583 M T 2.50Kg  AGA MG ND NR + 6/10 8/10 8/10 + 7.32 T N S- - D 1.53 
42. 432714 M T 2.80Kg  AGA P CS NR + 1/10 8/10 8/10 + 7.28 T N S- 1 D 1.78 
43. 432502 M PD 3.00Kg  AGA P ND NR - 5/10 9/10 9/10 + 7.35 T N S+ - D 1.20 
44. 433398 F T 3.96Kg  AGA MG ND R - 4/10 8/10 8/10 + 7.30 T N S- - D 1.24 
45. 433575 M T 3.05Kg  AGA MG ND NR + 2/10 5/10 7/10 + 7.24 T↓ S+ 2 D 2.38 
46. 432720 M PD 3.00Kg  AGA P ND R + 2/10 8/10 8/10 + 7.31 T↓ S+ 2 D 2.20 
47. 423766 M PD 2.80Kg  AGA P ND NR + 1/10 3/10 6/10 + 7.14 T↓ S+ 3 Expired 4.48 
48. 423924 F T 3.20Kg  AGA P ND NR - 1/10 5/10 6/10 + 7.22 T↓ S+ 2 D 2.38 
49. 424593 M T 3.50Kg  AGA P CS NR + 6/10 9/10 9/10 + 7.38 T N S- - D 0.78 
50. 424491 F T 2.50Kg  AGA P ND NR + 3/10 9/10 9/10 + 7.36 T N S- - D 0.98 
 
 
 
 
 
 
  
MASTER CHART OF CONTROLS 
SL.
NO IP NO SEX GAA BW MH MOD 
FD 
 
APGAR RES ABG NE UUA/CR 
 NST MSAF 1′ 5′ 10′   
1. 427653 F T 2.50 Kg  
AGA 
P LSCS R - 8/10 9/10 9/10 - - T N S- 0.76 
2. 427654 F T 2.50 Kg  
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 0.82 
3. 429020 M T 2.80 Kg  
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.81 
4. 428424 F T 2.50Kg  
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 0.91 
5. 427542 F T 3.50 Kg  
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 1.18 
6. 427549 F T 3.20 Kg  
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 1.22 
7. 427652 M T 2.60Kg  
AGA 
MG ND R 
- 
7/10 9/10 9/10 - - T N S- 0.98 
8. 427456 M T 2.70Kg  
AGA 
MG ND R 
- 
7/10 8/10 8/10 - - T N S- 0.87 
9. 427662 M T 2.80Kg  
AGA 
P ND R - 7/10 9/10 9/10 - - T N S- 0.90 
10. 427659 M T 3.00 Kg  
AGA 
P LSCS R - 7/10 8/10 8/10 - - T N S- 1.22 
11. 427661 F T 3.70Kg  
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.60 
12. 427810 M T 2.40Kg 
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.70 
13. 427536 F T 2.90Kg 
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 1.00 
14. 427467 M T 2.80Kg 
AGA 
P ND R - 8/10 9/10 9/10 - - T N S- 0.70 
15. 427772 F T 2.60Kg 
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.70 
16. 427779 M T 3.07Kg 
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 0.90 
17. 427814 F T 2.40.Kg AGA MG ND R - 7/10 9/10 9/10 - - T N S- 0.70 
18. 427818 M T 2.70Kg 
AGA 
P ND R - 8/10 9/10 9/10 - - T N S- 1.08 
19. 427823 M T` 2.80g AGA P ND R - 8/10 9/10 9/10 - - T N S- 0.80 
20. 427826 M T 3.00Kg 
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 1.00 
21. 427827 M T 3.10Kg 
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 0.60 
22. 427835 F T 2.70Kg  
AGA 
P ND R - 7/10 9/10 9/10 - - T N S- 0.90 
23. 427838 F T 2.90Kg  
AGA 
P ND R - 7/10 9/10 9/10 - - T N S- 0.79 
24. 427894 F T 2.80Kg  
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.91 
25. 427911 M T 2.50Kg  
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.76 
26. 427812 M T 2.80Kg  
AGA 
P ND R - 8/10 9/10 9/10 - - T N S- 0.68 
27. 427912 M T 2.60Kg  
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 1.23 
28. 430082 F T 2.50Kg  
AGA 
P ND R - 8/10 9/10 9/10 - - T N S- 0.60 
29. 430489 F T 2.50Kg  
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 0.72 
30. 430638 F T 2.70Kg  
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.61 
31. 430534 M T 2.70Kg   
AGA 
MG ND R - 7/10 8/10 9/10 - - T N S- 0.82 
32. 437715 M T 2.90Kg  
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.94 
33. 431239 M T 2.60Kg  
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 0.76 
34. 431326 M T 3.20Kg  
AGA 
MG ND R - 7/10 8/10 9/10 - - T N S- 0.84 
35. 431076 M T 3.20Kg  
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 1.01 
  
  
36. 431640 M T 4.20Kg  
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.66 
37. 431874 M T 2.50Kg  
AGA 
P ND R - 7/10 9/10 9/10 - - T N S- 1.00 
38. 431862 M T 2.30Kg  
AGA 
P ND R - 7/10 9/10 9/10 - - T N S- 0.78 
39. 431428 M T 3.00Kg  
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.64 
40. 432080 M T 3.30Kg  
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.42 
41. 432169 M T 2.60Kg   
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.55 
42. 432239 F T 2.60Kg   
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 0.61 
43. 433240 M T 3.50Kg   
AGA 
P ND R - 7/10 8/10 8/10 - - T N S- 0.42 
44. 432282 F T 3.00Kg   
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.83 
45. 423477 F T 3.20Kg   
AGA 
MG ND R - 8/10 9/10 9/10 - - T N S- 0.81 
46. 432491 F T 2.80Kg   
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.92 
47. 432237 M T 2.90Kg   
AGA 
P ND R - 7/10 9/10 9/10 - - T N S- 0.99 
48. 432214 M T 2.50Kg   
AGA 
P ND R - 8/10 9/10 9/10 - - T N S- 1.01 
49. 432314 F T 2.50Kg   
AGA 
MG ND R - 7/10 8/10 8/10 - - T N S- 1.22 
50. 432350 F T 3.10Kg   
AGA 
MG ND R - 7/10 9/10 9/10 - - T N S- 0.45 
